How to Verify a Janoshik COA: Task ID, HPLC, and the Tests Most Sellers Skip

What a "Janoshik COA" Actually Is

Janoshik Analytical is an independent third-party laboratory used by a long list of research peptide vendors. The reason a Janoshik COA carries more weight than a vendor's in-house document is simple: the lab is not selling the product. In-house testing creates a conflict of interest. Independent testing removes it.

A Janoshik report comes with a unique task ID. That number is the verification key. It ties one specific sample to one specific test on one specific date. A peptide certificate of analysis without a verifiable task ID is closer to marketing than evidence, regardless of what number is printed on it.

Janoshik can run HPLC purity, LC-MS identity, mass spectrometry analysis, peptide assay, endotoxin (LAL), residual TFA, heavy metals, and a few other panels. Whether a vendor pays for the full set or only the cheapest test is a choice. The COA reflects the choice.

Most Peptide Sellers Do Not Publish a Real Janoshik COA

Walk a peptide buyer through the COA pages of the top fifty vendors that show up for searches like "research peptides Dubai" or "buy peptides UAE" and a clear pattern appears. Most do not publish a Janoshik COA at all. Some publish a single PDF that is reused across many products. A smaller group publishes a Janoshik HPLC report, but only HPLC. A very small number publish HPLC plus identity plus the full safety panel.

The split looks roughly like this in our sweeps of the UAE and broader GCC market:

A separate pattern is worth calling out. Many vendors prominently advertise "third-party tested" or "independently tested" on product pages and never publish the actual report. The phrasing is in marketing copy, headers, and trust badges. The Janoshik task ID, the chromatogram, the assay number, the endotoxin result, all of it is missing. "Third-party tested" without a viewable report is a claim, not evidence. The five-field check below is what turns the claim into proof: if the buyer cannot match compound, batch, date, lab, and task ID against a published report, the claim is unverified.

The takeaway is not that everyone in the lower tiers is selling fake material. It is that the documentation gap is real, and a buyer who asks for proof is asking for something most vendors cannot produce on the day. The vendors who can produce it are usually the same ones absorbing the testing cost on every batch.

The Cost Gap Behind the COA Gap

Janoshik publishes its testing prices openly. The numbers are not the point. The structure is. HPLC purity is the cheapest analytical procedure on the menu. LC-MS identity and peptide assay sit a step up. Endotoxin (USP <85> bacterial endotoxins testing), residual TFA, and heavy metals sit higher again because each is a separate analytical procedure with its own sample preparation, instrument, and turnaround.

Roughly speaking, a vendor that runs only HPLC pays a small fraction of what a vendor running the full panel pays per batch. The full panel can easily cost several times more than HPLC alone. Multiplied across many products and many production runs, that is a meaningful operating-cost line. It is the main reason the published-COA market splits so cleanly into tiers:

None of this is hidden. Janoshik will quote the panel for any buyer who asks. The reason most vendors do not publish endotoxin or heavy metals is not that the data is hard to obtain. It is that paying for it on every batch lowers margin, and printing only the headline HPLC number is enough for buyers who are not asking the next question.

A research buyer who is asking the next question is also the buyer most likely to repeat-purchase. That is the calculation behind a full-panel program.

The Five Fields You Actually Have to Match

A serious COA verification takes about five minutes. The goal is to confirm that the report in front of you describes the material in front of you, on a date that is current, by a lab you can name, with a task ID you could verify if you wanted to.

1. Compound name. The COA must name the same molecule the product page claims. "Retatrutide", "tirzepatide", "BPC-157", and so on.
2. Batch number. A Remy retatrutide pen batch looks like RET-20-C-2604-001 or RETP002. The same batch ID has to appear on the report and on the product or label you received.
3. Test date. A current report is one tied to the current production run. Old dates can still be valid if the batch has not changed, but they should match the batch.
4. Lab name. "Janoshik Analytical" should appear on the report, not just in marketing copy. In-house testing is not equivalent.
5. Janoshik task ID. A unique ID per report. This is the verification key. If a buyer asks Janoshik directly with the task ID, the lab can confirm the report is real.

If any one of these five is missing, the document is not a verification layer. It is a marketing artifact. That is true regardless of how high the printed purity number is.

HPLC Purity Is Not Net Peptide Content

Two numbers get confused on COAs constantly. HPLC purity describes the chromatogram: how much of the detected peptide-related signal under that method belongs to the target compound. A result like 99.841% HPLC means the target peak made up 99.841% of the detected signal.

Net peptide content is a different question. The final peptide product also contains water, TFA salts, counter ion content, and residual solvents. A peptide can test at 99% HPLC and still have a net peptide content of 70 to 85 percent. That gap is not a problem in itself for research peptides. It only becomes a problem when a vendor uses HPLC purity as if it answered the assay or content question. It does not.

For research peptide work where concentration matters, both numbers matter. The HPLC chromatogram tells you the peak is clean. A separate assay tells you how much target compound is actually in the vial.

LC-MS Identity: The Name Has to Match the Mass

A clean HPLC peak proves cleanliness, not identity. Identity is the job of LC-MS or mass spectrometry analysis. The instrument ionizes the peptide and measures the mass-to-charge ratio of each ion, which produces a molecular fingerprint for every compound exiting the column.

A confirmed identity means the measured mass matches the theoretical mass calculated from the peptide sequence within an acceptance limit (typically 5 ppm or less). For a research buyer, this is what catches a basic but serious problem: a product can look clean by one method while still being the wrong compound, a close analogue, or a mislabeled batch. A vendor comfortable showing identity testing is a vendor who is not relying on a single percentage to do every job.

Endotoxin, TFA, and Heavy Metals: The Tests Almost No One Publishes

Even among vendors that publish a Janoshik HPLC report per batch, very few publish the safety panel. This is the section of the COA where the seller gap is widest.

Endotoxin testing looks for bacterial endotoxins, usually reported in EU per vial or EU per mL. The pharmacopeial reference is USP <85>. A published endotoxin number does not turn a research compound into a medicine, and Remy does not claim it does. It is still useful evidence of deeper quality control on the batch.

Residual TFA measures whether trifluoroacetic acid carry-over from synthesis remains detectable in the finished material. Heavy metals testing screens for arsenic, cadmium, lead, and mercury. None of these are glamorous numbers. They are the kind of boring documentation that makes a batch easier to trust at the receiving end.

The reason most peptide sellers do not publish these tests is partly cost (each line is paid per batch) and partly risk: a published endotoxin or heavy-metals failure is harder to ignore than a missing field. Skipping the test entirely is easier than failing it on paper. A buyer should treat that absence as part of the data.

Walkthrough: Reading Remy Batch RET-20-V-2604-001

The vial-line batch is a useful example because it carries the full panel, not just HPLC. Apply the five-field check first, then read the panel.

For comparison, the pen-line batch RET-20-C-2604-001 currently carries the highest published Remy purity at 99.841% HPLC, Janoshik task #150762, with a measured concentration of 22.51 mg/mL. The legacy 30mg pen reference batch RETP002 sits at 99.262% HPLC. Each batch carries its own report. None of the three is reused as a stand-in for the others.

Red Flags on a Fake or Stale Janoshik COA

• No task ID. A Janoshik report without the task ID cannot be verified against the lab's records.
• Cropped images. A report that hides batch number, date, or task ID is hiding the parts you need to verify.
• One COA across many products. Different formats and batches should not point to the same proof.
• Old dates with new packaging. A report from two years ago does not describe a batch that was just produced.
• HPLC only, presented as full proof. A clean chromatogram is necessary but not sufficient. No identity, no assay, no safety panel means the rest of the questions are unanswered.
• Lab name absent or unverifiable. "Tested in our laboratory" is not third-party testing.
• Medical or treatment language around a research product. Outcome claims are a separate compliance warning, not a quality signal. Research peptides should be described for in-vitro laboratory research, not as medicines or personal-use protocols.

A buyer who is unsure can ask the vendor for the task ID directly and check that field against the published report. A vendor that cannot produce the task ID on request is the answer to the question.

How to Verify a Janoshik Task ID

The verification flow is short.

1. Open the vendor's COA page for the batch you bought.
2. Read the task ID off the published report.
3. Compare the report against the five fields above (compound, batch, date, lab, task ID).
4. If anything is missing, ask the vendor for the source PDF directly. A vendor that cannot send it is telling you something.
5. For deeper verification, the task ID can be checked against Janoshik's records by contacting the lab. The number is the lookup key.

For research-use buyers in the UAE and broader GCC, this is not paperwork for its own sake. It is the layer that lets a lab build a clean research chain instead of one stitched together from supplier claims. See the peptide COA HPLC guide for the deeper read on what each test means individually, and the Dubai peptide legality guide for the regulatory framing under MoHAP Circular 17/2022.